To determine direct cost, drug utilization, and complications in Covid-19 positive pediatric populatio
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/01/039676
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 176
Inclusion Criteria
Pediatric inpatients of both gender
Age less than 18 yrs. (As per the National Commission for Protection of Child Rights, a child is defined as a person from 0 to 18 years of age irrespective of their gender)
Symptomatic patients
Pediatric patients with evidence of recent COVID-19 infection (RT-PCR positive), or likely contact with patients with COVID-19
Pediatric patients diagnosed with MIS-C
Exclusion Criteria
Patients who are on alternative system of medicine such as Ayurveda system
Patients with missing RT-PCR positive report of insufficient medical data
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Data on demographic features and treatment aspects of pediatric COVID-19 patients.Timepoint: 24 weeks
- Secondary Outcome Measures
Name Time Method ength of hospital stay, utilization of intensive care, and financial burden of hospitalization.Timepoint: 24 Weeks